Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/decellularized-scaffolds.md — the filesystem corpus, unchanged. Not an edit.
13.2 kB
Revision 1
Revision 2
lines 8–14 → 8–147 unchanged lines not shown
categories: ["bodies"]categories: ["bodies"]tags: ["extracellular matrix", "regenerative medicine", "transplantation", "biomaterials", "research misconduct", "tissue engineering"]tags: ["extracellular matrix", "regenerative medicine", "transplantation", "biomaterials", "research misconduct", "tissue engineering"]summary: "Donor tissues stripped of their cells to leave an extracellular matrix scaffold, used as surgical implants and as a route to rebuilding whole organs from a preserved vascular tree."summary: "Donor tissues stripped of their cells to leave an extracellular matrix scaffold, used as surgical implants and as a route to rebuilding whole organs from a preserved vascular tree."updated: "2026-07-27"updated: "2026-10-29"humanEvidence: "Acellular matrix implants are in routine surgical use in people, and a small uncontrolled study reported new muscle formation at sites of traumatic muscle loss; recellularized whole organs remain a rodent result."humanEvidence: "Acellular matrix implants are in routine surgical use in people, and a small uncontrolled study reported new muscle formation at sites of traumatic muscle loss; recellularized whole organs remain a rodent result."access: "Acellular dermis, submucosa, heart valves and nerve grafts are approved surgical products in wide use; no recellularized whole organ is available at any price."access: "Acellular dermis, submucosa, heart valves and nerve grafts are approved surgical products in wide use; no recellularized whole organ is available at any price."reversibility: "difficult"reversibility: "difficult"lines 34–40 → 34–4019 unchanged lines not shown
## How it works## How it works Decellularization removes cellular material without destroying the matrix that surrounds it — a balance, since every agent aggressive enough to lyse cells also degrades matrix components.Decellularization removes cellular material without destroying the matrix that surrounds it. Doing so is a balance, since every agent aggressive enough to lyse cells also degrades matrix components. Ionic detergents such as sodium dodecyl sulfate strip cells efficiently but denature proteins and remove glycosaminoglycans and matrix-bound growth factors. Non-ionic detergents such as Triton X-100 are gentler and less complete. Most protocols combine them with enzymatic steps, usually a nuclease to digest residual DNA, and with physical treatments such as freeze-thaw cycling.Ionic detergents such as sodium dodecyl sulfate strip cells efficiently but denature proteins and remove glycosaminoglycans and matrix-bound growth factors. Non-ionic detergents such as Triton X-100 are gentler and less complete. Most protocols combine them with enzymatic steps, usually a nuclease to digest residual DNA, and with physical treatments such as freeze-thaw cycling. lines 44–54 → 44–543 unchanged lines not shown
## What the matrix does## What the matrix does An acellular matrix is not inert packing. It carries laminin and fibronectin binding sites that direct cell attachment, collagen architecture that sets stiffness and alignment, and sequestered growth factors released as the matrix is degraded. Stephen Badylak's work established that implanted matrix does not simply persist as a scaffold but is remodelled: it recruits host cells, degrades over weeks, and biases infiltrating macrophages toward a reparative rather than inflammatory phenotype, producing what he termed constructive remodelling. In a small clinical study, matrix implants placed into sites of traumatic volumetric muscle loss were associated with new muscle formation and functional improvement.[^sicari2014] The result is modest against the standard set by animals capable of true [[limb-regeneration]], and it is the closest thing to induced structural regeneration achieved in human patients.An acellular matrix is not inert packing. It carries laminin and fibronectin binding sites that direct cell attachment, collagen architecture that sets stiffness and alignment, and sequestered growth factors released as the matrix is degraded. Stephen Badylak's work established that implanted matrix does not simply persist as a scaffold but is remodelled: it recruits host cells, degrades over weeks, and biases infiltrating macrophages toward a reparative rather than inflammatory phenotype, producing what he termed constructive remodelling. In a small clinical study, matrix implants placed into sites of traumatic volumetric muscle loss were associated with new muscle formation and functional improvement.[^sicari2014] The result is modest against the standard set by animals capable of true [[limb-regeneration]], but it is the closest thing to induced structural regeneration achieved in human patients. Digested matrix is also used as a culture substrate, replacing tumour-derived basement membrane gel in [[organoids]] work and serving as a tissue-specific component of printable bioinks.This immunological steering is now understood as central rather than incidental. It connects to the finding, established in mice rather than in patients, that scaffold-driven regeneration depends on type 2 immune signalling, discussed in [[tissue-engineering]]. This immunological steering is now understood as central rather than incidental, and connects to the finding, established in mice rather than in patients, that scaffold-driven regeneration depends on type 2 immune signalling, discussed in [[tissue-engineering]].Digested matrix is also used as a culture substrate, replacing tumour-derived basement membrane gel in [[organoids]] work and serving as a tissue-specific component of printable bioinks. ## Products in routine use## Products in routine use lines 56–62 → 56–621 unchanged line not shown
Acellular human dermal matrix is used in breast reconstruction, abdominal wall repair and burn care. Porcine small intestinal submucosa is used for hernia repair, wound care and soft tissue reinforcement. Decellularized human and porcine heart valves are implanted, particularly in children, where a valve that the recipient's cells can populate and that grows with the patient is worth a great deal. Decellularized nerve allografts are a standard option for bridging peripheral nerve gaps. Decellularized bone and tendon are widespread in orthopaedics.Acellular human dermal matrix is used in breast reconstruction, abdominal wall repair and burn care. Porcine small intestinal submucosa is used for hernia repair, wound care and soft tissue reinforcement. Decellularized human and porcine heart valves are implanted, particularly in children, where a valve that the recipient's cells can populate and that grows with the patient is worth a great deal. Decellularized nerve allografts are a standard option for bridging peripheral nerve gaps. Decellularized bone and tendon are widespread in orthopaedics. None of these is a lab-grown organ. They are matrices that the patient's body converts into tissue, which is a lower bar and a more reliable one.None of these is a lab-grown organ. Each is a matrix that the patient's body converts into tissue, a lower bar and a more reliable one. ## Whole-organ decellularization## Whole-organ decellularization lines 72–78 → 72–789 unchanged lines not shown
Each of the rodent results represented a genuine first and a small fraction of native function. The decellularized rat heart generated a fraction of the pressure of a working heart; the reseeded kidney produced urine far more dilute than a native one. Scaling to human organs multiplies the cell requirement roughly a thousandfold and lengthens every diffusion path. Supplying that many cells of the right types is itself a manufacturing problem, addressed in most current work by differentiating [[induced-pluripotent-stem-cells]], and for the heart the practical alternative has remained the mechanical pump described in [[artificial-heart]].Each of the rodent results represented a genuine first and a small fraction of native function. The decellularized rat heart generated a fraction of the pressure of a working heart; the reseeded kidney produced urine far more dilute than a native one. Scaling to human organs multiplies the cell requirement roughly a thousandfold and lengthens every diffusion path. Supplying that many cells of the right types is itself a manufacturing problem, addressed in most current work by differentiating [[induced-pluripotent-stem-cells]], and for the heart the practical alternative has remained the mechanical pump described in [[artificial-heart]]. The specific barrier is the endothelium. A decellularized vascular tree presents bare collagen to blood, which is thrombogenic; unless the entire luminal surface is recoated with functional endothelial cells, the graft clots within hours of perfusion. The interaction of blood with an imperfect artificial surface is the same constraint that governs mechanical circulatory support and the oxygen carriers described in [[artificial-blood]]. Achieving complete re-endothelialization across the whole tree, including capillaries, has not been demonstrated at human scale. The practical response has been to lower the goal: rather than an implantable organ, an externally perfused humanized pig liver used as temporary support for liver failure, where blood contacts the device outside the body and anticoagulation is manageable.The specific barrier is the endothelium. A decellularized vascular tree presents bare collagen to blood, which is thrombogenic; unless the entire luminal surface is recoated with functional endothelial cells, the graft clots within hours of perfusion. The interaction of blood with an imperfect artificial surface is the same constraint that governs mechanical circulatory support and the oxygen carriers described in [[artificial-blood]]. Achieving complete re-endothelialization across the whole tree, including capillaries, has not been demonstrated at human scale. The practical response has been to lower the goal from an implantable organ to an externally perfused humanized pig liver, used as temporary support for liver failure, where blood contacts the device outside the body and anticoagulation is manageable. ## The Macchiarini case## The Macchiarini case lines 81–91 → 81–912 unchanged lines not shown
Four Karolinska clinicians who raised concerns were investigated and reprimanded before the allegations were substantiated. An external inquiry found misconduct, Macchiarini was dismissed in 2016, and a 2011 paper describing the synthetic trachea was retracted in 2018. Swedish courts pursued criminal charges; an appeals court convicted him of gross assault in 2023 and imposed a prison sentence.Four Karolinska clinicians who raised concerns were investigated and reprimanded before the allegations were substantiated. An external inquiry found misconduct, Macchiarini was dismissed in 2016, and a 2011 paper describing the synthetic trachea was retracted in 2018. Swedish courts pursued criminal charges; an appeals court convicted him of gross assault in 2023 and imposed a prison sentence. > [!caution] What the case actually shows> [!caution] What the case actually shows> The failure was not that the technology was implausible in principle. It was procedural: no controls, no preclinical foundation, patient selection driven by the surgeon, institutional incentives favouring a celebrated recruit, and a compassionate-use pathway that permitted repeated first-in-human procedures without accumulating evidence. Any regenerative therapy can be run this way, and the safeguards that failed were not specific to tracheas. The structural resemblance to the death of Jesse Gelsinger, which set back [[somatic-gene-therapy]] by years, and to the [[he-jiankui-affair]] is close: in each case a researcher moved to humans ahead of the evidence, and institutional review either failed or was bypassed.> The failure was procedural, and it does not show that the technology was implausible in principle. The procedures had no controls and no preclinical foundation, patient selection was driven by the surgeon, institutional incentives favoured a celebrated recruit, and a compassionate-use pathway permitted repeated first-in-human procedures without accumulating evidence. Any regenerative therapy can be run this way, and the safeguards that failed were not specific to tracheas. The structural resemblance to the death of Jesse Gelsinger, which set back [[somatic-gene-therapy]] by years, and to the [[he-jiankui-affair]] is close: in each case a researcher moved to humans ahead of the evidence, and institutional review either failed or was bypassed. ## Limitations## Limitations Beyond re-endothelialization, four constraints recur. Residual antigens in xenogeneic matrix, notably the alpha-gal epitope that also drives rejection in [[xenotransplantation]], provoke immune responses even after cells are removed. Detergent residues are cytotoxic and hard to wash out of dense matrix. Decellularization degrades mechanical strength, which matters for valves and vessels expected to last decades. And obtaining human donor organs to decellularize competes with using them directly, so the scalable version of the approach depends on animal organs, with the antigenicity that implies.Beyond re-endothelialization, four constraints recur. Residual antigens in xenogeneic matrix, such as the alpha-gal epitope that also drives rejection in [[xenotransplantation]], provoke immune responses even after cells are removed. Detergent residues are cytotoxic and hard to wash out of dense matrix. Decellularization degrades mechanical strength, which matters for valves and vessels expected to last decades. And obtaining human donor organs to decellularize competes with using them directly, so the scalable version of the approach depends on animal organs, with the antigenicity that implies. Regulators have responded to the trachea cases by tightening the compassionate-use route for engineered tissues, an instance of the [[precautionary-principle]] operating retrospectively: the restrictions arrived after the deaths rather than before them.Regulators have responded to the trachea cases by tightening the compassionate-use route for engineered tissues, an instance of the [[precautionary-principle]] operating retrospectively: the restrictions arrived after the deaths rather than before them. removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
105 lines are the same in both revisions, and 64 of them are not shown. Neither revision here is necessarily the current article — read Decellularized scaffolds for the text this wiki stands behind today.